P2.13-21 MET Addiction Can Be Circumvented Through EGFR Inhibition via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1416
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition

PLoS ONE
Multidisciplinary
2017English

Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Inhibition of EGFR Induces a C-Met-Driven Stem Cell Population in Glioblastoma

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2014English

Urea Cycle Sustains Cellular Energetics Upon EGFR Inhibition in EGFR Mutant NSCLC

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Tumors Resistant to EGFR Inhibitors Can Arise via Different Mechanisms

Cancer Discovery
Oncology
2016English

AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling

Cancer Discovery
Oncology
2015English

The Persistent Promise of Combining HGF/MET and EGFR Inhibition in Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy